Proactive For Her, the leading omnichannel women's health clinic in India, is excited to announce the opening of three more clinic locations—Whitefield, New BEL Rd and JP Nagar—in Bangalore.
Transcenta Holdings, a global biotherapeutics firm with completely coordinated capacities in the revelation, examination, improvement and assembling of immune response-based therapeutics, and Agilent Technologies, declare cooperation to...
P&G Health, a global leader in nerve care and makers of Neurobion, achieved a new GUINNESS WORLD RECORDS title for the ‘Largest online photo album of people wearing pin badges’.
Boehringer Ingelheim Biopharmaceuticals China (BioChina), a pharmaceutical firm, has effectively passed pre-endorsement investigations by the European Medicines Agency (EMA) and the US Food and Medication Organization (FDA). The customer...
Cynata Therapeutics Restricted, a clinical-stage biotechnology firm, declared the culmination of patient enrolment in its stage 1 clinical preliminary of CYP-006TK in diabetic foot ulcers (DFU). CYP-006TK is Cynata's Cymerus iPSC1-inferred MSC2...
The biotechnology firm Ocugen, Inc., specializes in finding, creating, and bringing to market innovative gene and cell therapies as well as vaccines. Recently, the Data and Safety Monitoring Board (DSMB) for the phase 1/2 ArMaDa clinical trial of...
ErlySign, a pioneering biotech start-up located in Nagpur, announces a significant milestone in the fight against cancer with approval from the Indian regulatory agency CDSCO for its active salivary biomarker study designed for early cancer detection
The Piramal Group, a leading Global Business Conglomerate, declared a Rs 110-crore interest in Biodeal Pharmaceuticals. The contract improvement and assembling organization will send the investment mixed by Piramal Options for working on its...
On the occasion of World Health Day 2024, CAHO (Consortium of Accredited Healthcare Organizations), a distinguished not-for-profit organization committed to advancing quality initiatives within Indian healthcare establishments, proudly announces...
Johnson and Johnson, a pharmaceutical industry firm, has declared a conclusive arrangement to acquire all outstanding Shockwave Medical, Inc. shares for $335.00 per share in real money. This transaction relates to a venture worth roughly $13.1...
, CDSCO.jpg)
